Science
Merck & Co Inc/Handout via Reuters
Japanese Pharma Firm Joins Pfizer and Merck in Race to Develop COVID Pill Cure
GULP
Osaka-based Shionogi has joined Pfizer and Merck in a race to develop a daily pill that will neutralize COVID-19 in infected patients.
